Concepedia

Joshua Hoenisch

JH

5

Publications

166

Citations

5

H-Index

2019

Active since

Affiliations

University of British Columbia(Current)

BC Cancer Agency

University of Calgary

Centre Hospitalier de l’Université de Montréal

Joshua Hoenisch is an author at University of British Columbia specializing in ovarian cancer, medicine, and pathology.

ORCID

Top concepts

Publications per year

2019–2022

5

Publications

5

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target

Marta Llauradó Fernández, Amy Dawson, Joshua Hoenisch et al. · Cancer Cell International · 2019 · 44 citations · Full text

Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma

Marta Llauradó Fernández, Amy Dawson, Hannah Kim et al. · Gynecologic Oncology · 2020 · 42 citations

, , +8

Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability

Raunak Shrestha, Marta Llauradó Fernández, Amy Dawson et al. · Cancer Research · 2021 · 38 citations · Full text

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression

Dane Cheasley, Marta Llauradó Fernández, Martin Köbel et al. · npj Precision Oncology · 2022 · 27 citations · Full text

NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition

Marta Llauradó Fernández, E. Marielle Hijmans, Annemiek M.C. Gennissen et al. · Molecular Cancer Therapeutics · 2022 · 15 citations · Full text

, , +14

Rows per page

1–5 of 5